Project Details
Description
The objective of this contract is twofold. The first objective is to continue to utilize appropriate papillomavirus animal model systems to evaluate the efficiency of experimental antiviral substances to control papillomavirus infections. The second is to integrate in vitro systems to permit the mechanistic analysis of experimental therapies. In addition, the models will continue to provide badly needed information on the natural history and pathogenesis of papillomavirus infections.
| Status | Finished |
|---|---|
| Effective start/end date | 7/1/98 → 6/30/01 |
Funding
- National Institute of Allergy and Infectious Diseases: $319,411.00
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.